Screener
Arcus Biosciences RCUS Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Late-stage development programs (1) | 51 | 74 | 111 | 129 |
| Early-stage development and preclinical programs (2) | 21 | 38 | 39 | 80 |
| Compensation and personnel costs | 58 | 61 | 129 | 128 |
| Depreciation and amortization | 2 | 2 | 5 | 5 |
| Interest income, net | (5) | (8) | (11) | (18) |
| Other segment items (3) | 22 | 26 | 40 | 47 |
| Partnership reimbursements | (17) | (33) | (36) | (71) |
| Segment net income (loss) and Consolidated net income (loss) | $(91) | — | $(219) | $(112) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's interest expense?
- Arcus Biosciences (RCUS) reported interest expense of $3M in Q2 2026.
- How has Arcus Biosciences's interest expense changed year-over-year?
- Arcus Biosciences's interest expense increased by 50.0% year-over-year, from $2M to $3M.
- What is the long-term trend for Arcus Biosciences's interest expense?
- Over 2 years (2022 to 2025), Arcus Biosciences's interest expense has grown at a 100.0% compound annual growth rate (CAGR), from $2M to $8M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Arcus Biosciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude